Acute Coronary Syndrome

Clinical cardiology

Antiplatelet Therapy: When the Evidence Meets the Experience

Oct 1, 2008 10:15 EDT

The optimal management of patients with ACS is an ever-evolving process; clinical experience and practice often outpace guidelines. Watch Drs Bohm, Camm, Fox, Mehta, and Connolly address the state-of-the-art management of ACS and the role of antiplatelets in ACS and beyond.

Acute Coronary Syndrome

Focus on bleeding

Sep 23, 2008 09:17 EDT

Bleeding in ACS patients has been associated with increased adverse cardiac events and negative patient outcomes. Join Dr Deepak Bhatt and panelists Drs Ehtisham Mahmud and Gabriel Steg as they discuss the treatment options and strategies to reduce bleeding in patients with ACS.

Acute Coronary Syndrome

Antiplatelet/anticoagulant Treatment Recommendations in the STEMI Guidelines

1 COMMENT - Sep 15, 2008 09:56 EDT

Antiplatelet therapy and anticoagulant therapy are the foundations for the treatment of acute coronary syndromes (ACS). Join Dr Eric Bates and panelists Drs Gabriel Steg, Robert Storey and Steen Dalby Kristensen as they discuss new guideline recommendations for the use of antiplatelet therapy and anticoagulant therapy in patients experiencing an acute coronary syndrome (ACS).

Acute Coronary Syndrome

The FellowShip series: What is a bleed and what does it mean in clinical practice?

Sep 9, 2008 17:00 EDT

Bleeding in ACS patients has been associated with increased adverse cardiac events and negative patient outcomes. Join Drs Gilles Montalescot and Johanne Silvain as they discuss a case of bleeding and review treatment strategies to improve outcomes and minimize adverse events for these patients.

Acute Coronary Syndrome

Updates to the STEMI Guidelines

1 COMMENT - Aug 18, 2008 15:25 EDT

Both the US and the European Guidelines for the Management of STEMI have recently been revised to reflect new data specific to the management and treatment of STEMI patients. Join Dr E Magnus Ohman and panelists Drs Robert Harrington, Robert Storey and Jean-Pierre Bassand as they discuss the differences between the US and the European STEMI Guidelines as well as the optimal management goals for patients with STEMI.

Acute Coronary Syndrome

The Science and Medicine of Circulatory Dysfunction and Acute Pressure Syndromes

Aug 18, 2008 09:37 EDT

An investigator and clinical scholar, Dr. Christopher Granger, MD, the program chairman, and his distinguished colleagues illuminate the emerging threats and clinical challenges cardiologists face when managing patients who present with, or undergo, acute, severe, serious, precipitous, and/or life-threatening elevations in systemic blood pressure.

Acute Coronary Syndrome

Highlights from oral antiplatelet therapy for acute and chronic management of ischaemic heart disease

2 COMMENTS - Jul 18, 2008 14:09 EDT

With several new oral antiplatelet agents looming large on the horizon, don't miss this unique opportunity to hear the experts share new clinical data and analysis!

Acute Coronary Syndrome

EDICT for ACS: Milestone Practice Advances in STEMI and ACUTE CORONARY SYNDROME

Jun 27, 2008 12:22 EDT

Distinguished faculty members of The Year 2008 EDICT (Emergency Department and Interventional Cardiology Therapeutic teams) for ACS initiative are pleased to invite you to participate in a regional, science-to-strategy summit focused on upstream and downstream management of patients with STEMI and UA/NSTEMI.

Clinical cardiology

Thienopyridines in PCI: The lowdown on loading doses

Jun 23, 2008 11:00 EDT

Current guidelines for thienopyridines in PCI note the lack of RCT data for higher loading doses. Read Dr Wang's lowdown on loading doses, including recent presentations from the 2008 SCAI-ACCi2 meeting. Then watch Drs Mehta and Mehran discuss where CURRENT-OASIS-7 will fit in.

Acute Coronary Syndrome

Optimising outcomes in acute coronary syndromes: role of new approaches to platelet inhibition

5 COMMENTS - Jun 3, 2008 14:22 EDT

Balancing antithrombotic efficacy with risk of bleeding: Join our international panel of experts, Steen Husted, José Carlos Nicolau, Sunil Rao and Robert Storey as they review the mechanisms of platelet activation and emerging evidence from ongoing studies to novel antiplatelet therapies.

Acute Coronary Syndrome

Highlights from Antiplatelet therapy for percutaneous coronary intervention

1 COMMENT - May 27, 2008 11:33 EDT

Drs Badimon, Kristensen, Spaulding and Storey explore the most appropriate treatments, based on an understanding of the intensive inhibition of platelet aggregation with dual antiplatelet therapy.

Acute Coronary Syndrome

Antiplatelet nonresponder

2 COMMENTS - May 27, 2008 11:16 EDT

Antiplatelet therapy is the mainstay for the treatment of acute coronary syndromes (ACS). Although antiplatelet agents reduce ischemic events, "resistance" to their effects continues to occur. Join Drs Harvey White and Christian Hamm in a discussion of a clinical case of a patient that has developed resistance.

Acute Coronary Syndrome

The Science and Medicine of Acute Coronary Syndrome

May 21, 2008 09:26 EDT

This program will address new dimensions and practice advances with scientific rigor and expert analysis, including case studies.

Acute Coronary Syndrome

Door to Door STEMI Care

2 COMMENTS - Apr 22, 2008 16:48 EDT

Important issues surrounding the care of patients with acute coronary syndrome (ACS) - the safety and efficacy of medical management vs invasive strategies and balancing efficacy against the increased risk for bleeding - have been discussed at several recent meetings. The volume of newly released data surrounding the treatment of patients with ACS has led to confusion as to what is the best therapeutic option for a given patient. Join Ph Gabriel Steg MD and panelists Christian Hamm MD and Harvey White MD as they contextualize these data and discuss the applicability to clinical practice

Acute Coronary Syndrome

Highlights from Antiplatelet Therapy During PCI: New Perspectives

Apr 21, 2008 13:00 EDT

Dual antiplatelet therapy with aspirin and clopidogrel is the standard of care for patients during PCI. Even utilizing this standard, adverse clinical events do occur. This activity will review clinical data pertinent to the current state of antiplatelet therapy for the management of patients during PCI. This will include a discussion of the scope of adverse clinical events, efficacy of current antiplatet agents, antiplatelet resistance, and next-generation antiplatelet therapies, which will give attendees current and emerging treatment options for the management of patients during PCI.

Acute Coronary Syndrome

Antiplatelet trials: What is to come in 2008 and beyond

1 COMMENT - Apr 17, 2008 12:00 EDT

Antiplatelet therapy is the mainstay for the treatment of acute coronary syndromes (ACS). Currently, there are several new investigational agents being studied to treat ACS. Please join Dr Magnus Ohman as he describes the design and rationale of their ongoing clinical trials and puts the potential impact of these future data into perspective.

Interventional/Surgery

The FellowShip Series: Late stent thrombosis - a case study panel discussion

4 COMMENTS - Apr 14, 2008 17:30 EDT

Dr Topol leads a case-study based discussion with three Fellows on late stent thrombosis.

Acute Coronary Syndrome

An update from the American College of Cardiology 2008 Scientific Sessions/i2 Summit-SCAI Annual Meeting

Apr 14, 2008 10:13 EDT

Antiplatelet therapy involves a balance between the prevention of thrombosis and bleeding. The AHA 2007 Scientific Sessions program included the long-awaited results from TRITON and presentations on areas of uncertainty, including cost-effectiveness, loading dose, duration of therapy and resistance.

Acute Coronary Syndrome

Understanding stent thrombosis and antiplatelet therapy

2 COMMENTS - Apr 10, 2008 15:00 EDT

Antiplatelet therapy is an important component in the treatment of acute coronary syndromes (ACS). Join Dr Deepak Bhatt and panelists Drs Ehtisham Mahmud, Eric Peterson and Stephen Wiviott as they discuss intensifying antiplatelet therapy, stent thrombosis and the risk of early discontinuation of antiplatelet therapy.

Clinical cardiology

Lost in translation: US and European guidelines for the pharmacologic management of ACS

5 COMMENTS - Apr 10, 2008 14:00 EDT

If we're all looking at the same data, why do the European and US guidelines for the treatment of ACS differ in terms of initiation, dosing, and choices of pharmacological therapies? Drs Ohman, Montalescot, Pollack and Fox discuss the similarities and differences.

Acute Coronary Syndrome

Optimizing outcomes in STEMI patients

1 COMMENT - Apr 10, 2008 10:00 EDT

The volume of recently released - and sometimes conflicting - clinical trial data surrounding the treatment of patients with ACS has led to confusion as to what is the best therapeutic option for a given patient. Because of the varying results from these trials, clinicians currently struggle with what constitutes optimum antithrombin/antiplatelet strategy for patients with ACS. Join Dr Eric Bates and panelists Drs Peter Berger and Gregg Stone as they contextualize these data and discuss their applicability to clinical practice.

Acute Coronary Syndrome

Optimal antiplatelet therapy in NSTEMI: Timing and use of GpIIb/IIIa inhibitors

1 COMMENT - Mar 31, 2008 16:30 EDT

Join Drs Peterson, Pollack and Gurbel as they discuss controversies over the timing and choice of effective antiplatelet therapy in NSTEMI ACS.

Acute Coronary Syndrome

Antithrombotic therapy: A year in review

Feb 28, 2008 12:00 EST

2007 was an important year in antithrombotic therapy with the presentation of data from significant trials like TRITON-TIMI 38 and HORIZONS. Join Drs Bhatt, Wiviott and Stone as they examine these data and its role in the ever changing landscape of ACS care.

Clinical cardiology

Recent clinical trial data on adjunctive pharmacology in ACS patients undergoing PCI

Dec 27, 2007 12:30 EST

What is the future of adjunctive pharmacology given the results of the HORIZONS and TRITON trials?

Acute Coronary Syndrome

Acute STEMI: Overcoming Peri-Procedural Challenges in Patients Undergoing PCI

Dec 21, 2007 10:30 EST

As continued refinements in catheter-based device technology continue to occur, further increases in the number of interventional procedures will likely result. Despite the demonstrated clinical benefit of reperfusion strategies, substantial challenges exist in identifying the precise combination of therapeutic agents and interventional procedures that will maximize patient outcomes. In addition, intra-procedural complications occur and remain an important source of patient morbidity and mortality. Through a combination of lectures, case-based discussions, and audience interaction this activity will address the complexities of acute STEMI management, available reperfusion strategies, challenges to minimizing intra-procedural complications, and overall strategies to optimize patient outcomes. The faculty will discuss unique clinical challenges while emphasizing evidence-based treatment strategies.

	TIMI
	GUSTO
	PRISM-Plus
	PARAGON-B
	ACUITY
	CURE
	Other